These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 24785410)

  • 1. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy.
    Piers SR; Tao Q; van Huls van Taxis CF; Schalij MJ; van der Geest RJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):875-83. PubMed ID: 24036134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.
    Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality.
    Santangeli P; Muser D; Zado ES; Magnani S; Khetpal S; Hutchinson MD; Supple G; Frankel DS; Garcia FC; Bala R; Riley MP; Lin D; Rame JE; Schaller R; Dixit S; Marchlinski FE; Callans DJ
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):68-75. PubMed ID: 25491601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.
    Silberbauer J; Oloriz T; Maccabelli G; Tsiachris D; Baratto F; Vergara P; Mizuno H; Bisceglia C; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):424-35. PubMed ID: 24833642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.
    Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F
    Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial ventricular tachycardia ablation a multicenter safety study.
    Sacher F; Roberts-Thomson K; Maury P; Tedrow U; Nault I; Steven D; Hocini M; Koplan B; Leroux L; Derval N; Seiler J; Wright MJ; Epstein L; Haissaguerre M; Jais P; Stevenson WG
    J Am Coll Cardiol; 2010 May; 55(21):2366-72. PubMed ID: 20488308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig ventricular tachycardia registry.
    Dinov B; Arya A; Bertagnolli L; Schirripa V; Schoene K; Sommer P; Bollmann A; Rolf S; Hindricks G
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1144-51. PubMed ID: 25262159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.
    Berruezo A; Fernández-Armenta J; Andreu D; Penela D; Herczku C; Evertz R; Cipolletta L; Acosta J; Borràs R; Arbelo E; Tolosana JM; Brugada J; Mont L
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):326-36. PubMed ID: 25583983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the 12-lead electrocardiogram in localizing the scar in non-ischaemic cardiomyopathy.
    Oloriz T; Wellens HJ; Santagostino G; Trevisi N; Silberbauer J; Peretto G; Maccabelli G; Della Bella P
    Europace; 2016 Dec; 18(12):1850-1859. PubMed ID: 26589624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging.
    Piers SR; van Huls van Taxis CF; Tao Q; van der Geest RJ; Askar SF; Siebelink HM; Schalij MJ; Zeppenfeld K
    Eur Heart J; 2013 Feb; 34(8):586-96. PubMed ID: 23161702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleomorphic Ventricular Tachycardias in Nonischemic Cardiomyopathy.
    Nazer B; Hsia HH
    Card Electrophysiol Clin; 2016 Mar; 8(1):131-7. PubMed ID: 26920181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of unipolar and bipolar voltage mapping identifies recurrences after unmappable scar-related ventricular tachycardia ablation.
    Yalin K; Golcuk E; Bilge AK; Aksu T; Buyukbayrak H; Tiryakioglu SK; Emet S; Adalet K
    Europace; 2015 Oct; 17(10):1580-6. PubMed ID: 25750215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence.
    Frankel DS; Mountantonakis SE; Zado ES; Anter E; Bala R; Cooper JM; Deo R; Dixit S; Epstein AE; Garcia FC; Gerstenfeld EP; Hutchinson MD; Lin D; Patel VV; Riley MP; Robinson MR; Tzou WS; Verdino RJ; Callans DJ; Marchlinski FE
    J Am Coll Cardiol; 2012 Apr; 59(17):1529-35. PubMed ID: 22516442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.